1 | lines | 5,239 |
2 | envelopes | 209 |
3 | monolayers | 179 |
4 | saver | 59 |
5 | histiocytosis | 32 |
6 | culture-derived | 31 |
7 | line-derived | 22 |
8 | dyscrasia | 17 |
9 | sorter | 15 |
10 | magnetometry | 12 |
11 | quotas | 10 |
12 | activation/dysfunction | 5 |
13 | autovaccine | 5 |
14 | mobilizer | 4 |
15 | praecox | 4 |
16 | protease-1 | 4 |
17 | ssmyd88 | 4 |
18 | trait/disease | 4 |
19 | acanthocytosis | 3 |
20 | bio-nano-chip | 3 |
21 | bioformulation | 3 |
22 | cycle- | 3 |
23 | lipografts | 3 |
24 | neocentric | 3 |
25 | sheen | 3 |
26 | shwasa | 3 |
27 | thermoautotrophicum | 3 |
28 | whiskers® | 3 |
29 | adhesion/invasion | 2 |
30 | cytocortex | 2 |
31 | denaturalization | 2 |
32 | frcs | 2 |
33 | headform | 2 |
34 | hymens | 2 |
35 | il-6-deficient | 2 |
36 | line-6 | 2 |
37 | re-stimulations | 2 |
38 | transfusions.repeated | 2 |
39 | unscathed | 2 |
40 | -hexa-pep | 1 |
41 | -tetra-pep2 | 1 |
42 | 139:267-284 | 1 |
43 | 157/834 | 1 |
44 | 4p14-p15 | 1 |
45 | adhesion/migration | 1 |
46 | all-silicone- | 1 |
47 | autoantiobodies | 1 |
48 | azazirconacycles | 1 |
49 | biol42 | 1 |
50 | biology/biochemistry | 1 |
51 | c57bl/6-kit | 1 |
52 | cell-stents | 1 |
53 | counts/100 | 1 |
54 | culture-passaged | 1 |
55 | cycle-induced | 1 |
56 | cycle-positive | 1 |
57 | cytoclasis | 1 |
58 | cytokine-and | 1 |
59 | death-apoptosis | 1 |
60 | death-is | 1 |
61 | defunctionalisation | 1 |
62 | depletion/reconstitution | 1 |
63 | dermaroller | 1 |
64 | dihydroxy-derivatives | 1 |
65 | disease.analyses | 1 |
66 | disease.though | 1 |
67 | disease.while | 1 |
68 | dyscohesion | 1 |
69 | dysfunction/injury | 1 |
70 | ems-mutant | 1 |
71 | epidermis.journal | 1 |
72 | factor-analytically | 1 |
73 | fratricide | 1 |
74 | fuhction | 1 |
75 | gradedly | 1 |
76 | growth/division | 1 |
77 | growth/survival/proliferation | 1 |
78 | ileocolonocystoplasty | 1 |
79 | immunoglobulin-3 | 1 |
80 | induced-angiogenesis | 1 |
81 | injury/death | 1 |
82 | k-pins | 1 |
83 | kinetic-chains | 1 |
84 | laporscope | 1 |
85 | leukemia-3 | 1 |
86 | liens | 1 |
87 | line-5 | 1 |
88 | line-adapted | 1 |
89 | lines-hep-2 | 1 |
90 | lines-nci-h460 | 1 |
91 | lines/tissues | 1 |
92 | loading-corresponding | 1 |
93 | lymphoma/lewkmia-2 | 1 |
94 | lymphoma‑2 | 1 |
95 | meshworks | 1 |
96 | metabolism/acidosis | 1 |
97 | microelectrophoresis | 1 |
98 | minichamber | 1 |
99 | mono-nitrobenzenes | 1 |
100 | multi-breed | 1 |
101 | nb4-bearing | 1 |
102 | nephrotoxity | 1 |
103 | npc-specific | 1 |
104 | number.figure | 1 |
105 | oligo-azoospermia | 1 |
106 | orientation-falls | 1 |
107 | percentage/concentration | 1 |
108 | pm₂.₅₋₀.₃-exposed | 1 |
109 | proliferation-a | 1 |
110 | proliferation.accordingly | 1 |
111 | proliferation/death | 1 |
112 | protein.hour | 1 |
113 | protein/hr | 1 |
114 | pyrochlores | 1 |
115 | receptors-one | 1 |
116 | saver-generated | 1 |
117 | signaling-modulating | 1 |
118 | sorter-staining | 1 |
119 | strainer | 1 |
120 | survival/cem43 | 1 |
121 | therapy-eventually | 1 |
122 | thermo-transition | 1 |
123 | transkeotlase | 1 |
124 | transketolate | 1 |
125 | triply-substituted | 1 |
126 | viability.we | 1 |
127 | wall-perturbing | 1 |
128 | wall/procyanidin | 1 |
1 | -hexa-pep | 1 |
2 | -tetra-pep2 | 1 |
3 | 139:267-284 | 1 |
4 | 157/834 | 1 |
5 | 4p14-p15 | 1 |
6 | acanthocytosis | 3 |
7 | activation/dysfunction | 5 |
8 | adhesion/invasion | 2 |
9 | adhesion/migration | 1 |
10 | all-silicone- | 1 |
11 | autoantiobodies | 1 |
12 | autovaccine | 5 |
13 | azazirconacycles | 1 |
14 | bio-nano-chip | 3 |
15 | bioformulation | 3 |
16 | biol42 | 1 |
17 | biology/biochemistry | 1 |
18 | c57bl/6-kit | 1 |
19 | cell-stents | 1 |
20 | counts/100 | 1 |
21 | culture-derived | 31 |
22 | culture-passaged | 1 |
23 | cycle- | 3 |
24 | cycle-induced | 1 |
25 | cycle-positive | 1 |
26 | cytoclasis | 1 |
27 | cytocortex | 2 |
28 | cytokine-and | 1 |
29 | death-apoptosis | 1 |
30 | death-is | 1 |
31 | defunctionalisation | 1 |
32 | denaturalization | 2 |
33 | depletion/reconstitution | 1 |
34 | dermaroller | 1 |
35 | dihydroxy-derivatives | 1 |
36 | disease.analyses | 1 |
37 | disease.though | 1 |
38 | disease.while | 1 |
39 | dyscohesion | 1 |
40 | dyscrasia | 17 |
41 | dysfunction/injury | 1 |
42 | ems-mutant | 1 |
43 | envelopes | 209 |
44 | epidermis.journal | 1 |
45 | factor-analytically | 1 |
46 | fratricide | 1 |
47 | frcs | 2 |
48 | fuhction | 1 |
49 | gradedly | 1 |
50 | growth/division | 1 |
51 | growth/survival/proliferation | 1 |
52 | headform | 2 |
53 | histiocytosis | 32 |
54 | hymens | 2 |
55 | il-6-deficient | 2 |
56 | ileocolonocystoplasty | 1 |
57 | immunoglobulin-3 | 1 |
58 | induced-angiogenesis | 1 |
59 | injury/death | 1 |
60 | k-pins | 1 |
61 | kinetic-chains | 1 |
62 | laporscope | 1 |
63 | leukemia-3 | 1 |
64 | liens | 1 |
65 | line-5 | 1 |
66 | line-6 | 2 |
67 | line-adapted | 1 |
68 | line-derived | 22 |
69 | lines | 5,239 |
70 | lines-hep-2 | 1 |
71 | lines-nci-h460 | 1 |
72 | lines/tissues | 1 |
73 | lipografts | 3 |
74 | loading-corresponding | 1 |
75 | lymphoma/lewkmia-2 | 1 |
76 | lymphoma‑2 | 1 |
77 | magnetometry | 12 |
78 | meshworks | 1 |
79 | metabolism/acidosis | 1 |
80 | microelectrophoresis | 1 |
81 | minichamber | 1 |
82 | mobilizer | 4 |
83 | mono-nitrobenzenes | 1 |
84 | monolayers | 179 |
85 | multi-breed | 1 |
86 | nb4-bearing | 1 |
87 | neocentric | 3 |
88 | nephrotoxity | 1 |
89 | npc-specific | 1 |
90 | number.figure | 1 |
91 | oligo-azoospermia | 1 |
92 | orientation-falls | 1 |
93 | percentage/concentration | 1 |
94 | pm₂.₅₋₀.₃-exposed | 1 |
95 | praecox | 4 |
96 | proliferation-a | 1 |
97 | proliferation.accordingly | 1 |
98 | proliferation/death | 1 |
99 | protease-1 | 4 |
100 | protein.hour | 1 |
101 | protein/hr | 1 |
102 | pyrochlores | 1 |
103 | quotas | 10 |
104 | re-stimulations | 2 |
105 | receptors-one | 1 |
106 | saver | 59 |
107 | saver-generated | 1 |
108 | sheen | 3 |
109 | shwasa | 3 |
110 | signaling-modulating | 1 |
111 | sorter | 15 |
112 | sorter-staining | 1 |
113 | ssmyd88 | 4 |
114 | strainer | 1 |
115 | survival/cem43 | 1 |
116 | therapy-eventually | 1 |
117 | thermo-transition | 1 |
118 | thermoautotrophicum | 3 |
119 | trait/disease | 4 |
120 | transfusions.repeated | 2 |
121 | transkeotlase | 1 |
122 | transketolate | 1 |
123 | triply-substituted | 1 |
124 | unscathed | 2 |
125 | viability.we | 1 |
126 | wall-perturbing | 1 |
127 | wall/procyanidin | 1 |
128 | whiskers® | 3 |
1 | cycle- | 3 |
2 | all-silicone- | 1 |
3 | counts/100 | 1 |
4 | lines-nci-h460 | 1 |
5 | protease-1 | 4 |
6 | lymphoma/lewkmia-2 | 1 |
7 | lines-hep-2 | 1 |
8 | biol42 | 1 |
9 | -tetra-pep2 | 1 |
10 | lymphoma‑2 | 1 |
11 | leukemia-3 | 1 |
12 | immunoglobulin-3 | 1 |
13 | survival/cem43 | 1 |
14 | 157/834 | 1 |
15 | 139:267-284 | 1 |
16 | line-5 | 1 |
17 | 4p14-p15 | 1 |
18 | line-6 | 2 |
19 | ssmyd88 | 4 |
20 | proliferation-a | 1 |
21 | oligo-azoospermia | 1 |
22 | dyscrasia | 17 |
23 | shwasa | 3 |
24 | npc-specific | 1 |
25 | neocentric | 3 |
26 | cycle-induced | 1 |
27 | multi-breed | 1 |
28 | culture-passaged | 1 |
29 | unscathed | 2 |
30 | pm₂.₅₋₀.₃-exposed | 1 |
31 | transfusions.repeated | 2 |
32 | saver-generated | 1 |
33 | line-adapted | 1 |
34 | triply-substituted | 1 |
35 | line-derived | 22 |
36 | culture-derived | 31 |
37 | cytokine-and | 1 |
38 | fratricide | 1 |
39 | disease.while | 1 |
40 | autovaccine | 5 |
41 | receptors-one | 1 |
42 | laporscope | 1 |
43 | number.figure | 1 |
44 | trait/disease | 4 |
45 | transkeotlase | 1 |
46 | transketolate | 1 |
47 | cycle-positive | 1 |
48 | viability.we | 1 |
49 | wall-perturbing | 1 |
50 | loading-corresponding | 1 |
51 | sorter-staining | 1 |
52 | nb4-bearing | 1 |
53 | signaling-modulating | 1 |
54 | disease.though | 1 |
55 | proliferation/death | 1 |
56 | injury/death | 1 |
57 | epidermis.journal | 1 |
58 | headform | 2 |
59 | thermoautotrophicum | 3 |
60 | sheen | 3 |
61 | wall/procyanidin | 1 |
62 | adhesion/invasion | 2 |
63 | dyscohesion | 1 |
64 | growth/division | 1 |
65 | bioformulation | 3 |
66 | growth/survival/proliferation | 1 |
67 | adhesion/migration | 1 |
68 | percentage/concentration | 1 |
69 | defunctionalisation | 1 |
70 | denaturalization | 2 |
71 | fuhction | 1 |
72 | activation/dysfunction | 5 |
73 | thermo-transition | 1 |
74 | depletion/reconstitution | 1 |
75 | -hexa-pep | 1 |
76 | bio-nano-chip | 3 |
77 | minichamber | 1 |
78 | dermaroller | 1 |
79 | strainer | 1 |
80 | sorter | 15 |
81 | saver | 59 |
82 | mobilizer | 4 |
83 | protein/hr | 1 |
84 | protein.hour | 1 |
85 | quotas | 10 |
86 | frcs | 2 |
87 | autoantiobodies | 1 |
88 | azazirconacycles | 1 |
89 | mono-nitrobenzenes | 1 |
90 | lines | 5,239 |
91 | envelopes | 209 |
92 | pyrochlores | 1 |
93 | disease.analyses | 1 |
94 | lines/tissues | 1 |
95 | dihydroxy-derivatives | 1 |
96 | death-is | 1 |
97 | cytoclasis | 1 |
98 | induced-angiogenesis | 1 |
99 | microelectrophoresis | 1 |
100 | metabolism/acidosis | 1 |
101 | death-apoptosis | 1 |
102 | acanthocytosis | 3 |
103 | histiocytosis | 32 |
104 | meshworks | 1 |
105 | orientation-falls | 1 |
106 | liens | 1 |
107 | hymens | 2 |
108 | kinetic-chains | 1 |
109 | k-pins | 1 |
110 | re-stimulations | 2 |
111 | monolayers | 179 |
112 | lipografts | 3 |
113 | cell-stents | 1 |
114 | c57bl/6-kit | 1 |
115 | ems-mutant | 1 |
116 | il-6-deficient | 2 |
117 | cytocortex | 2 |
118 | praecox | 4 |
119 | gradedly | 1 |
120 | proliferation.accordingly | 1 |
121 | factor-analytically | 1 |
122 | therapy-eventually | 1 |
123 | magnetometry | 12 |
124 | biology/biochemistry | 1 |
125 | dysfunction/injury | 1 |
126 | nephrotoxity | 1 |
127 | ileocolonocystoplasty | 1 |
128 | whiskers® | 3 |